Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 100 Total
IAF - abrdn Australia Equity Fund Inc - Stock Price Chart
TickerIAF [NYSE]
Companyabrdn Australia Equity Fund Inc
CountryUSA
IndustryClosed-End Fund - Equity
Market Cap124.04MEPS (ttm)1.29
P/E3.47EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S27.64EPS next 5Y-
P/B0.89EPS Q/Q-
Dividend10.94%Sales Q/Q-6.30%
Insider Own-Inst Own33.02%
Insider Trans-Inst Trans-
Short Float0.05%Earnings-
Analyst Recom-Target Price-
Avg Volume52.41K52W Range3.35 - 4.75
Abrdn Australia Equity Fund Inc is a closed ended equity mutual fund launched and managed by Aberdeen Standard Investments (Asia) Limited. The fund is managed by Aberdeen Standard Investments Australia Limited. It invests in the public equity markets of Australia. The fund makes its investments in firms operating across diversified sectors. It employs fundamental analysis with a bottom-up and top-down stock picking approach with focus on factors like growth prospects, competitive positions in domestic and export markets, technology, research and development, productivity, labor and raw material costs, profit margins, return on investment, capital resources, quality of management, and government regulation to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P ASX 200 Accumulation Index. It also uses proprietary research to create its portfolio. The Aberdeen Australia Equity Fund Inc. was previously known as The First Australia Fund, Inc. Abrdn Australia Equity Fund Inc was formed in September 30, 1985 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SELL MORITZ ADirectorJul 02 '25Buy4.502,0009,0003,000Jul 03 10:04 AM
RGCO - RGC Resources, Inc - Stock Price Chart
TickerRGCO [NASD, RUT]
CompanyRGC Resources, Inc
CountryUSA
IndustryUtilities - Regulated Gas
Market Cap231.90MEPS (ttm)1.29
P/E17.47EPS this Y7.76%
Forward P/E17.43EPS next Y3.20%
PEG-EPS past 5Y1.47%
P/S2.54EPS next 5Y-
P/B1.97EPS Q/Q17.59%
Dividend3.63%Sales Q/Q11.64%
Insider Own20.20%Inst Own38.06%
Insider Trans0.04%Inst Trans1.65%
Short Float0.78%EarningsMay 08/b
Analyst Recom1.00Target Price27.00
Avg Volume13.58K52W Range19.05 - 24.20
RGC Resources, Inc. is a holding company, which engages in the distribution and sale of natural gas to residential, commercial, and industrial users in its service territory. The firm operates through the following segments: Gas Utility, Investment in Affiliates, and Parent and Other. The Gas Utility segment focuses on tariff rates and other regulatory mechanisms through which it provides for the sale and distribution of natural gas to customers. The Investment in Affiliates includes investment activities in MVP and Southgate projects. The Parent and Other segment consists of unregulated activities and corporate eliminations. The company was founded on July 31, 1998 and is headquartered in Roanoke, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Furcron Thomas PatrickVP, Field OperationsJul 01 '25Buy22.84194301,016Jul 03 09:31 AM
Miles Christen BrookeVP, Human ResourcesJul 01 '25Buy22.8441006,720Jul 03 09:29 AM
Oliver Lawrence T.VP and SecretaryJul 01 '25Buy22.84920023,535Jul 03 09:27 AM
Furcron Thomas PatrickVP, Field OperationsJun 24 '25Sale22.162726,026997Jul 02 10:39 AM
Oliver Lawrence T.VP and SecretaryJun 02 '25Buy20.461020023,526Jun 04 08:52 AM
CULP - Culp Inc - Stock Price Chart
TickerCULP [NYSE]
CompanyCulp Inc
CountryUSA
IndustryTextile Manufacturing
Market Cap57.40MEPS (ttm)-1.53
P/E-EPS this Y100.65%
Forward P/E12.35EPS next Y3600.00%
PEG-EPS past 5Y6.75%
P/S0.27EPS next 5Y-
P/B1.00EPS Q/Q57.68%
Dividend-Sales Q/Q-1.52%
Insider Own10.92%Inst Own62.93%
Insider Trans23.54%Inst Trans-3.46%
Short Float0.36%EarningsJun 25/a
Analyst Recom1.00Target Price8.00
Avg Volume17.60K52W Range3.42 - 6.85
Culp, Inc. engages in the design, manufacture, and trade of mattresses and upholstery products. It operates through the Mattress Fabrics and Upholstery Fabrics segments. The Mattress Fabrics segment markets and sells covers and beddings under the Culp Home Fashions brand. The Upholstery Fabrics segment produces and supplies fabrics for residential and commercial manufacturers. The company was founded by Robert G. Culp, Jr. and Robert G. Culp, III in 1972 and is headquartered in High Point, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CULP ROBERT GEORGE IVPresident & CEOJul 01 '25Buy4.1512,00049,800104,030Jul 03 09:25 AM
Kelly Jonathan LeeFormer DirectorMar 24 '25Buy5.407003,78249,521Mar 25 04:11 PM
English Aron R.10% OwnerMar 18 '25Buy5.35104,738560,3481,839,061Mar 20 05:31 PM
English Aron R.10% OwnerMar 19 '25Buy5.6020,000111,9541,859,061Mar 20 05:31 PM
Kelly Jonathan LeeFormer DirectorMar 18 '25Buy5.332501,33248,821Mar 20 08:46 AM
CLRB - Cellectar Biosciences Inc - Stock Price Chart
TickerCLRB [NASD]
CompanyCellectar Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap13.07MEPS (ttm)-22.45
P/E-EPS this Y58.04%
Forward P/E-EPS next Y14.81%
PEG-EPS past 5Y40.27%
P/S-EPS next 5Y31.04%
P/B0.97EPS Q/Q84.21%
Dividend-Sales Q/Q-
Insider Own2.85%Inst Own6.34%
Insider Trans258.12%Inst Trans-
Short Float6.34%EarningsMay 13/b
Analyst Recom1.67Target Price90.00
Avg Volume454.13K52W Range4.36 - 94.50
Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124, which could detect tumors and metastases in a broad range of cancers, and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. The company was founded on June 24, 1996 and is headquartered in Florham Park, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARUSO JAMES VChief Executive OfficerJul 02 '25Buy4.9910,00049,90011,638Jul 03 08:02 AM
Longcor JarrodChief Operating OfficerJul 02 '25Buy4.9910,00049,90012,768Jul 03 08:01 AM
Kolean Chad JChief Financial OfficerJul 02 '25Buy4.995,00024,9506,418Jul 03 08:00 AM
Longcor JarrodChief Operating OfficerJan 10 '25Buy0.2830,0008,40083,141Mar 12 09:44 PM
NYC - American Strategic Investment Co - Stock Price Chart
TickerNYC [NYSE]
CompanyAmerican Strategic Investment Co
CountryUSA
IndustryReal Estate Services
Market Cap41.99MEPS (ttm)-55.98
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-6.37%
P/S0.71EPS next 5Y-
P/B0.54EPS Q/Q-3.53%
Dividend-Sales Q/Q-19.96%
Insider Own62.99%Inst Own1.78%
Insider Trans5.33%Inst Trans5.66%
Short Float2.22%EarningsMay 09/b
Analyst Recom3.00Target Price8.00
Avg Volume5.16K52W Range7.55 - 16.30
American Strategic Investment Co. is a publicly traded real estate investment trust that owns a portfolio of high-quality commercial real estate located within the five boroughs of New York City, particularly Manhattan. Its portfolio is diversified across eight office and retail condominium assets. The firm's top tenants feature a balance of large investment grade rated corporate tenants and government agencies. The company was founded on December 19, 2013 and is headquartered in Newport, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SCHORSCH NICHOLAS S10% OwnerJul 02 '25Buy14.831,64024,3211,014,934Jul 02 09:30 PM
SCHORSCH NICHOLAS S10% OwnerJul 01 '25Buy14.441,64023,6861,013,294Jul 02 09:30 PM
SCHORSCH NICHOLAS S10% OwnerJun 30 '25Buy13.091,64021,4681,011,654Jul 02 09:30 PM
SCHORSCH NICHOLAS S10% OwnerJun 26 '25Buy12.641,27916,1671,008,735Jun 27 09:30 PM
SCHORSCH NICHOLAS S10% OwnerJun 27 '25Buy12.511,27916,0001,010,014Jun 27 09:30 PM
BCDA - BioCardia Inc - Stock Price Chart
TickerBCDA [NASD]
CompanyBioCardia Inc
CountryUSA
IndustryBiotechnology
Market Cap13.15MEPS (ttm)-2.58
P/E-EPS this Y58.62%
Forward P/E-EPS next Y16.67%
PEG-EPS past 5Y40.58%
P/S-EPS next 5Y31.06%
P/B-EPS Q/Q56.76%
Dividend-Sales Q/Q-100.00%
Insider Own29.98%Inst Own4.47%
Insider Trans46.47%Inst Trans82.70%
Short Float0.54%EarningsMay 14/a
Analyst Recom1.00Target Price6.00
Avg Volume128.31K52W Range1.62 - 4.66
BioCardia, Inc. is a clinical-stage biotherapeutic company, which engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its pipeline includes CardiAMP, CardiALLO, PulmALLO, Helix Biotherapeutic Delivery System, and Morph DNA and Avance Steerable Introducers. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McClung DavidChief Financial OfficerJun 30 '25Buy2.084,8199,99947,950Jul 02 09:03 PM
Altman PeterPresident and CEOJun 30 '25Buy2.0824,09649,999165,862Jul 02 09:02 PM
STERTZER SIMON HDirectorJun 30 '25Buy2.0872,289150,000192,654Jul 02 09:02 PM
Blank Andrew ScottDirectorJun 30 '25Buy2.0872,289150,000346,023Jul 02 09:01 PM
Altman PeterPresident and CEOMay 30 '25Buy2.21100221141,766May 30 08:55 PM
INTZ - Intrusion Inc - Stock Price Chart
TickerINTZ [NASD]
CompanyIntrusion Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap41.58MEPS (ttm)-1.22
P/E-EPS this Y77.91%
Forward P/E-EPS next Y30.56%
PEG-EPS past 5Y-
P/S6.48EPS next 5Y-
P/B3.10EPS Q/Q88.13%
Dividend-Sales Q/Q56.94%
Insider Own11.51%Inst Own2.95%
Insider Trans0.05%Inst Trans139.46%
Short Float8.34%EarningsApr 29/a
Analyst Recom2.00Target Price6.75
Avg Volume537.13K52W Range0.35 - 7.34
Intrusion, Inc. is a cybersecurity company, which offers customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company was founded by T. Joe Head and G. Ward Paxton in September 1983 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scott AnthonyChief Executive OfficerJun 30 '25Buy1.951,0912,124654,872Jul 02 08:44 PM
Scott AnthonyChief Executive OfficerDec 31 '24Buy0.92250230653,781Jan 06 05:51 PM
PINSON KIMBERLYChief Financial OfficerDec 31 '24Buy0.9225023020,576Jan 06 05:50 PM
PINSON KIMBERLYChief Financial OfficerDec 27 '24Option Exercise0.765,0003,80020,076Jan 02 08:06 AM
Scott AnthonyChief Executive OfficerDec 27 '24Option Exercise0.7615,00011,400653,281Jan 02 08:05 AM
ICU - SeaStar Medical Holding Corp - Stock Price Chart
TickerICU [NASD]
CompanySeaStar Medical Holding Corp
CountryUSA
IndustryBiotechnology
Market Cap9.55MEPS (ttm)-3.30
P/E-EPS this Y76.62%
Forward P/E-EPS next Y34.84%
PEG-EPS past 5Y-
P/S22.21EPS next 5Y-
P/B9.69EPS Q/Q90.75%
Dividend-Sales Q/Q-
Insider Own4.31%Inst Own5.62%
Insider Trans17.67%Inst Trans1.02%
Short Float19.08%EarningsMay 14/a
Analyst Recom1.00Target Price7.00
Avg Volume6.33M52W Range0.31 - 9.56
Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chung KevinChief Medical OfficerJul 01 '25Option Exercise0.005,000048,184Jul 03 04:33 PM
Schlorff EricChief Executive OfficerJul 01 '25Option Exercise0.0021,667098,517Jul 03 04:33 PM
Baird Jennifer ADirectorJun 04 '25Option Exercise0.002,667018,000Jul 02 07:32 PM
Baird Jennifer ADirectorJun 30 '25Buy0.4210,0004,17428,000Jul 02 07:32 PM
Neuman JohnDirectorJun 24 '25Buy0.3640,00014,39680,000Jun 27 06:00 AM
EXOZ - eXoZymes Inc - Stock Price Chart
TickerEXOZ [NASD]
CompanyeXoZymes Inc
CountryUSA
IndustryBiotechnology
Market Cap82.11MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B9.24EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own77.38%Inst Own0.92%
Insider Trans0.05%Inst Trans-0.52%
Short Float0.90%EarningsMay 12/a
Analyst Recom-Target Price-
Avg Volume11.14K52W Range8.50 - 23.99
eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heltzen MichaelChief Executive OfficerJul 02 '25Buy10.221,04010,62910,629Jul 02 05:49 PM
Heltzen MichaelChief Executive OfficerJan 17 '25Buy10.781,76719,0483,872Jan 21 06:02 AM
Heltzen MichaelChief Executive OfficerJan 16 '25Buy10.721211,2972,105Jan 21 06:02 AM
Heltzen MichaelChief Executive OfficerNov 15 '24Buy11.101,98422,0221,984Nov 19 06:45 PM
FUND - Sprott Focus Trust Inc - Stock Price Chart
TickerFUND [NASD]
CompanySprott Focus Trust Inc
CountryUSA
IndustryClosed-End Fund - Equity
Market Cap232.78MEPS (ttm)0.06
P/E130.00EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S29.25EPS next 5Y-
P/B0.93EPS Q/Q-72.70%
Dividend7.74%Sales Q/Q0.30%
Insider Own51.65%Inst Own62.39%
Insider Trans2.44%Inst Trans-
Short Float0.18%Earnings-
Analyst Recom-Target Price-
Avg Volume38.41K52W Range6.21 - 8.23
Sprott Focus Trust, Inc. is a closed-ended equity mutual fund launched and managed by Sprott Asset Management, LP. The fund is co-managed by Sprott Asset Management USA Inc. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the Russell 3000 Index. It was formerly known as Royce Focus Trust, Inc. Sprott Focus Trust, Inc. was formed on March 2, 1988 and is domiciled in the United States.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GEORGE W WHITNEYSenior Portfolio ManagerJun 30 '25Buy7.41131,416973,7933,166,625Jul 02 04:41 PM
GEORGE W WHITNEYSenior Portfolio ManagerJun 30 '25Buy7.4164,913481,0057,931,254Jul 02 04:41 PM
GEORGE W WHITNEYSenior Portfolio ManagerJun 03 '25Sale7.2129,900215,473250,600Jun 03 05:57 PM
GEORGE W WHITNEYSenior Portfolio ManagerMar 28 '25Buy7.30134,139979,2153,112,855Apr 01 04:02 PM
GEORGE W WHITNEYSenior Portfolio ManagerMar 28 '25Buy7.3065,998481,7857,866,341Apr 01 04:02 PM
12345678910